Optimal time to take once-daily oral medications in clinical practice

International Journal of Clinical Practice

Volumn 62, Issue 10, 2008, Pages 1560-1571

  Zhu, L L ^a   Zhou, Q ^a   Yan, X F ^a   Zeng, S ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; AMLODIPINE BESYLATE; BENAZEPRIL; BETALOC ZOK; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN HEXETIL; CARDIZEM LA; CARVEDILOL; COREG CR; DILTIAZEM; DOXAZOSIN; DYNACIRC CR; ENALAPRIL; ESOMEPRAZOLE; IRBESARTAN; ISOSORBIDE; ISOSORBIDE 5 NITRATE; ISRADIPINE; LANSOPRAZOLE; LOSEC MUPS; METOPROLOL; NIFEDIPINE; NISOLDIPINE; OLMESARTAN; OMEPRAZOLE; PANTOPRAZOLE; PERINDOPRIL; PROPRANOLOL; QUINAPRIL; RABEPRAZOLE; RAMIPRIL; TELMISARTAN; TRANDOLAPRIL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALSARTAN; VERAPAMIL;

BEDTIME DOSAGE; CHRONOTHERAPY; CLINICAL PRACTICE; DRUG ACTIVITY; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERTENSION; INCIDENCE; LOW DRUG DOSE; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SUSTAINED DRUG RELEASE;

ADMINISTRATION, ORAL; ADVERSE DRUG REACTION REPORTING SYSTEMS; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; DRUG CHRONOTHERAPY; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 51349166597     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01871.x     Document Type: Review

References (72)

1. Lemmer B, Labrecque G. Chronopharmacology and chronotherapeutics: definitions and concepts. Chronobiol Int 1987 4 : 319 29.
2. Müssig S, Witzel L, Lühmann R et al. Morning and evening administration of pantoprazole: a study to compare the effect on 24-hour intragastric pH. Eur J Gastroenterol Hepatol 1997 9 : 599 602.
3. Hendel J, Hendel L, Aggestrup S. Morning or evening dosage of omeprazole for gastro-oesophageal reflux disease? Aliment Pharmacol Ther 1995 9 : 693 7.
4. Fraser AG, Sawyerr AM, Hudson M et al. Morning versus evening dosing of lansoprazole 30 mg daily on twenty-four-hour intragastric acidity in healthy subjects. Aliment Pharmacol Ther 1996 10 : 523 7.
5. Pehlivanov ND, Olyaee M, Sarosiek I et al. Comparison of morning and evening administration of rabeprazole for gastro-oesophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double-blind, cross-over study. Aliment Pharmacol Ther 2003 18 : 883 90.
6. Lazzaroni M, Sangaletti O, Bargiggia S et al. Twenty-four-hour intragastric acidity following early evening or bedtime administration of roxatidine in duodenal ulcer patients. Aliment Pharmacol Ther 1996 10 : 187 91.
7. Cortot A, Guillemot F, Moreau J et al. Influence of the timing of administration of 300 mg ranitidine on 24-hour gastric pH in patients with acute duodenal ulcer. Aliment Pharmacol Ther 1992 6 : 487 93.
8. 2 receptor antagonists: is bedtime administration too late? Gut 1987 28 : 451 4.
9. Savarino V, Mela GS, Scalabrini P et al. A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. Eur J Clin Pharmacol 1988 35 : 203 7.
10. Fogari R, Malacco E, Tettamanti F et al. Evening vs morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring. Br J Clin Pharmacol 1993 35 : 51 4.
11. Portaluppi F, Vergnani L, Manfredini R et al. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens 1995 8 : 719 26.
12. Hermida RC, Calvo C, Ayala DE et al. Dose- and administration time-dependent effects of nifedipine GITS on ambulatory blood pressure in hypertensive subjects. Chronobiol Int 2007 24 : 471 93.
13. Greminger P, Suter PM, Holm D et al. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Clin Investig 1994 72 : 864 9.
14. Nold G, Strobel G, Lemmer B. Morning vs evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press Monit 1998 3 : 17 25.
15. Qiu YG, Chen JZ, Zhu JH et al. Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate. Cardiovasc Drugs Ther 2003 17 : 335 41.
16. White WB, Mansoor GA, Pickering TG et al. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am J Hypertens 1999 12 : 806 14.
17. Kitahara Y, Saito F, Akao M et al. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients. J Cardiovasc Pharmacol 2004 43 : 68 73.
18. Ashizawa N, Seto S, Shibata Y et al. Bedtime administration of cilnidipine controls morning hypertension. Int Heart J 2007 48 : 597 603.
19. Carter BL. Optimizing delivery systems to tailor pharmacotherapy to cardiovascular circadian events. Am J Health Syst Pharm 1998 55 (Suppl. 3 S17 23.
20. Claas SA, Glasser SP. Long-acting diltiazem HCl for the chronotherapeutic treatment of hypertension and chronic stable angina pectoris. Expert Opin Pharmacother 2005 6 : 765 76.
21. Sista S, Lai JC, Eradiri O et al. Pharmacokinetics of a novel diltiazem HCl extended-release tablet formulation for evening administration. J Clin Pharmacol 2003 43 : 1149 57.
22. Pechère-Bertschi A, Nussberger J, Decosterd L et al. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients. J Hypertens 1998 16 : 385 93.
23. Smolensky MH, Hermida RC, Portaluppi F. Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension. Chronobiol Int 2007 24 : 171 81.
24. Hermida RC, Calvo C, Ayala DE et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol Int 2005 22 : 755 76.
25. Hermida RC, Calvo C, Ayala DE et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 2003 42 : 283 90.
26. Niegowska J, Niegowska M, Jasiński B. Telmisartan in monotherapy of essential hypertension in young men-time of drug administration and 24-hours blood pressure and heart rate. Pol Arch Med Wewn 2005 114 : 868 73.
27. Hermida RC, Ayala DE, Fernández JR et al. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 2007 50 : 715 22.
28. Grassos H, Kontogianni D, Goranitou G et al. Administration-Time- Dependent Effects of Candesartan on 24-Hour Blood Pressure Control in Hypertensive Patients. Fifteenth European Meeting on Hypertension, Milan, 17-21 June 2005.
29. Palatini P, Mos L, Motolese M et al. Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. Int J Clin Pharmacol Ther Toxicol 1993 31 : 295 300.
30. Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens 1997 15 : 205 11.
31. Palatini P, Racioppa A, Raule G et al. Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther 1992 52 : 378 83.
32. Zaslavskaia RM, Narmanova OZ, Teǐblium MM et al. Time-dependent effects of ramipril in patients with hypertension of 2 stage. Klin Med (Mosk) 1999 77 : 41 4.
33. Svensson P, de Faire U, Sleight P et al. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy. Hypertension 2001 38 : E28 32.
34. Kuroda T, Kario K, Hoshide S et al. Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients. Hypertens Res 2004 27 : 15 20.
35. Macchiarulo C, Pieri R, Mitolo DC et al. Management of antihypertensive treatment with Lisinopril: a chronotherapeutic approach. Eur Rev Med Pharmacol Sci 1999 3 : 269 75.
36. Sunaga K, Fujimura A, Shiga T et al. Chronopharmacology of enalapril in hypertensive patients. Eur J Clin Pharmacol 1995 48 : 441 5.
37. Fujimura A, Ebihara A, Shiigai T et al. Amelioration of enalapril-induced dry cough by changing dosing time from morning to evening: a preliminary trial. Jpn J Clin Pharmacol Ther 1999 30 : 741 4.
38. Koga H, Hayashi J, Yamamoto M et al. Prevention of morning surge of hypertension by the evening administration of carvedilol. Jpn Med Assoc 2005 4 : 398 403.
39. GlaxoSmithKline Clinical Trial Register. An Open-Label, Single Dose, Three Session, Partially Randomized, Crossover Study to Assess Morning and Evening Dosing of Carvedilol Phosphate CR Capsules in Healthy Adult Subjects. http://ctr.gsk.co.uk/Summary/carvedilol/I_105517_906.pdf (accessed 21 June 2008).
40. Hebert K, Arcement L, Horswell AR. Hurricanes and heart failure: a review of the who, what, when, and where of beta-blocker therapy. Curr Heart Fail Rep 2006 3 : 89 95.
41. Sica D, Frishman WH, Manowitz N. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (Innopran XL), a new chronotherapeutic formulation. Heart Dis 2003 5 : 176 81.
42. Saito Y, Yoshida S, Nakaya N et al. Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects: a double-blind comparative study. Arterioscler Thromb 1991 11 : 816 26.
43. Plakogiannis R, Cohen H. Optimal low-density lipoprotein cholesterol lowering - morning versus evening statin administration. Ann Pharmacother 2007 41 : 106 10.
44. Fauler G, Abletshauser C, Erwa W et al. Time-of-intake (morning versus evening) of extended-release fluvastatin in hyperlipemic patients is without influence on the pharmacodynamics (mevalonic acid excretion) and pharmacokinetics. Int J Clin Pharmacol Ther 2007 45 : 328 34.
45. Plakogiannis R, Cohen H, Taft D. Effects of morning versus evening administration of atorvastatin in patients with hyperlipidemia. Am J Health Syst Pharm 2005 62 : 2491 4.
46. Martin PD, Mitchell PD, Schneck DW. Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers. Br J Clin Pharmacol 2002 54 : 472 7.
47. Ozaydin M, Dede O, Dogan A et al. Effects of morning versus evening intake of atorvastatin on major cardiac event and restenosis rates in patients undergoing first elective percutaneous coronary intervention. Am J Cardiol 2006 97 : 44 7.
48. Kosoglou T, Statkevich P, Johnson-Levonas AO et al. Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet 2005 44 : 467 94.
49. Hanefeld M, Lang PD, Fischer S et al. Effects of a bezafibrate sustained release formulation on plasma lipoproteins in patients with hypercholesterolemia. Importance of timing of tablet intake for efficacy. Arzneimittelforschung 1988 38 : 1835 7.
50. Hanefeld M. Timing of intake of lipid lowering drugs: is that of importance? J Mol Med 1989 67 : 511 2.
51. Hermida RC, Calvo C, Ayala DE et al. Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol Int 2004 21 : 277 96.
52. Kirby RS, Chapple CR, Sethia K et al. Morning vs evening dosing with doxazosin in benign prostatic hyperplasia: efficacy and safety. Prostate Cancer Prostatic Dis 1998 1 : 163 71.
53. Hermida RC, Ayala DE, Calvo C et al. Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients. J Am Coll Cardiol 2005 46 : 975 83.
54. Hermida RC, Ayala DE, Calvo C et al. Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives. Hypertension 2005 46 : 1060 8.
55. Kriszbacher I, Koppán M, Bódis J. Aspirin for stroke prevention taken in the evening? Stroke 2004 35 : 2760 1.
56. Calvo C, Hermida RC, Ayala DE. Chronotherapy with torasemide in hypertensive patients: increased efficacy and therapeutic coverage with bedtime administration. Med Clin (Barc) 2006 127 : 721 9.
57. Nagayama H, Nagano K, Ikezaki A et al. Double-blind study of the chronopharmacotherapy of depression. Chronobiol Int 1991 8 : 203 9.
58. Usher RW, Beasley CM Jr., Bosomworth JC. Efficacy and safety of morning versus evening fluoxetine administration. J Clin Psychiatry 1991 52 : 134 6.
59. Bolk N, Visser TJ, Kalsbeek A et al. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients. Clin Endocrinol (Oxf) 2007 66 : 43 8.
60. Gomis R, Raptis SA, Ravella R. Appropriate timing of glimepiride administration in patients with type 2 diabetes mellitus: a study in Mediterranean countries. Endocrine 2000 13 : 117 21.
61. D'Alonzo GE, Smolensky MH, Feldman S et al. Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs evening administration. Chest 1995 107 : 406 12.
62. Brocks DR, Upward J, Davy M et al. Evening dosing is associated with higher plasma concentrations of pranlukast, a leukotriene receptor antagonist, in healthy male volunteers. Br J Clin Pharmacol 1997 44 : 289 91.
63. Trnavská Z, Vondra V, Elis J. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration. Arzneimittelforschung 1989 39 : 1149 51.
64. Reinberg A, Levi F. Clinical chronopharmacology with special reference to NSAIDs. Scand J Rheumatol Suppl 1987 65 : 118 22.
65. Lévi F, Le Louarn C, Reinberg A. Timing optimizes sustained-release indomethacin treatment of osteoarthritis. Clin Pharmacol Ther 1985 37 : 77 84.
66. Vinje O, Fagertun HE, Laerum E et al. Ketoprofen controlled release (CR) in the treatment of osteoarthrosis; a double blind, randomized multicentre study of single morning versus evening dose. Norwegian Study Group of General Practitioners. Scand J Prim Health Care 1993 11 : 91 7.
67. Perpoint B, Mismetti P, Simitsidis S et al. Dosing time optimizes sustained-release ketoprofen treatment of osteoarthritis. Chronobiol Int 1994 11 : 119 25.
68. Bruguerollea B, Labrecque G. Rhythmic pattern in pain and their chronotherapy. Adv Drug Dev Rev 2007 59 : 883 95.
69. Stengaard-Pedersen K, Ekesbo R, Karvonen AL et al. Celecoxib 200 mg q.d. is efficacious in the management of osteoarthritis of the knee or hip regardless of the time of dosing. Rheumatology (Oxford) 2004 43 : 592 5.
70. Markiewicz A, Semenowicz K. Time dependent changes in the pharmacokinetics of aspirin. Int J Clin Pharmacol Biopharm 1979 17 : 409 11.
71. Hermida RC, Ayala DE, Portaluppi F. Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv Drug Deliv Rev 2007 59 : 904 22.
72. Hermida RC, Ayala DE, Fernández JR et al. Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 2008 51 : 69 76.